Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Solomon

Showing results (1171-1180 of 1,873) with videos related to

Pageof 188
Sort By:
The Lancet. Diabetes & Endocrinology|March 24, 2017
Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trialJelena P Seferovic, Brian Claggett, Sara B Seidelmann, et al.
Circulation. Heart Failure|March 21, 2023
Urinary cGMP (Cyclic Guanosine Monophosphate)/BNP (B-Type Natriuretic Peptide) Ratio, Sacubitril/Valsartan, and Outcomes in Heart Failure With Reduced Ejection Fraction: An Analysis of the PARADIGM-HF TrialJawad H Butt, Wasyla Ibrahim, Pooja Dewan, et al.
European Journal of Heart Failure|April 8, 2024
Effects of sacubitril/valsartan according to polypharmacy status in PARAGON-HFShingo Matsumoto, Mingming Yang, Li Shen, et al.
JACC. Heart Failure|November 30, 2024
Upgrading Right Ventricular Pacing to Cardiac Resynchronization in HFrEF Patients Improves Symptoms and Functional OutcomesEperke Merkel, Robert Hatala, Mátyás Szigeti, et al.
Journal of Hypertension|July 30, 2011
The relationship between renal impairment and left ventricular structure, function, and ventricular-arterial interaction in hypertensionAmil M Shah, Carolyn S P Lam, Susan Cheng, et al.
Journal of the American Heart Association|February 8, 2022
Flu Vaccine and Mortality in Hypertension: A Nationwide Cohort StudyDaniel Modin, Brian Claggett, Mads Emil Jørgensen, et al.
Circulation. Heart Failure|October 26, 2018
IGFBP7 (Insulin-Like Growth Factor-Binding Protein-7) and Neprilysin Inhibition in Patients With Heart FailureJames L Januzzi, Milton Packer, Brian Claggett, et al.
American Heart Journal|July 11, 2006
Extent of coronary artery disease as a predictor of outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or bothRajesh Janardhanan, Satish Kenchaiah, Eric J Velazquez, et al.
Circulation. Heart Failure|March 11, 2016
Impact of Spironolactone on Longitudinal Changes in Health-Related Quality of Life in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist TrialEldrin F Lewis, Hae-Young Kim, Brian Claggett, et al.
Journal of the American College of Cardiology|May 22, 2023
Angiotensin-Neprilysin Inhibition in Patients With Mildly Reduced or Preserved Ejection Fraction and Worsening Heart FailureRobert J Mentz, Jonathan H Ward, Adrian F Hernandez, et al.
Pageof 188

Showing results (1171-1180 of 1,873) with videos related to

Sort By:
Pageof 188
The Lancet. Diabetes & Endocrinology|March 24, 2017
Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trialJelena P Seferovic, Brian Claggett, Sara B Seidelmann, et al.
Circulation. Heart Failure|March 21, 2023
Urinary cGMP (Cyclic Guanosine Monophosphate)/BNP (B-Type Natriuretic Peptide) Ratio, Sacubitril/Valsartan, and Outcomes in Heart Failure With Reduced Ejection Fraction: An Analysis of the PARADIGM-HF TrialJawad H Butt, Wasyla Ibrahim, Pooja Dewan, et al.
European Journal of Heart Failure|April 8, 2024
Effects of sacubitril/valsartan according to polypharmacy status in PARAGON-HFShingo Matsumoto, Mingming Yang, Li Shen, et al.
JACC. Heart Failure|November 30, 2024
Upgrading Right Ventricular Pacing to Cardiac Resynchronization in HFrEF Patients Improves Symptoms and Functional OutcomesEperke Merkel, Robert Hatala, Mátyás Szigeti, et al.
Journal of Hypertension|July 30, 2011
The relationship between renal impairment and left ventricular structure, function, and ventricular-arterial interaction in hypertensionAmil M Shah, Carolyn S P Lam, Susan Cheng, et al.
Journal of the American Heart Association|February 8, 2022
Flu Vaccine and Mortality in Hypertension: A Nationwide Cohort StudyDaniel Modin, Brian Claggett, Mads Emil Jørgensen, et al.
Circulation. Heart Failure|October 26, 2018
IGFBP7 (Insulin-Like Growth Factor-Binding Protein-7) and Neprilysin Inhibition in Patients With Heart FailureJames L Januzzi, Milton Packer, Brian Claggett, et al.
American Heart Journal|July 11, 2006
Extent of coronary artery disease as a predictor of outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or bothRajesh Janardhanan, Satish Kenchaiah, Eric J Velazquez, et al.
Circulation. Heart Failure|March 11, 2016
Impact of Spironolactone on Longitudinal Changes in Health-Related Quality of Life in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist TrialEldrin F Lewis, Hae-Young Kim, Brian Claggett, et al.
Journal of the American College of Cardiology|May 22, 2023
Angiotensin-Neprilysin Inhibition in Patients With Mildly Reduced or Preserved Ejection Fraction and Worsening Heart FailureRobert J Mentz, Jonathan H Ward, Adrian F Hernandez, et al.
Pageof 188